Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2005 Mar 12;330(7491):571.
doi: 10.1136/bmj.38336.664352.82. Epub 2005 Feb 18.

International retrospective cohort study of neural tube defects in relation to folic acid recommendations: are the recommendations working?

Affiliations
Multicenter Study

International retrospective cohort study of neural tube defects in relation to folic acid recommendations: are the recommendations working?

Lorenzo D Botto et al. BMJ. .

Abstract

Objectives: To evaluate the effectiveness of policies and recommendations on folic acid aimed at reducing the occurrence of neural tube defects.

Design: Retrospective cohort study of births monitored by birth defect registries.

Setting: 13 birth defects registries monitoring rates of neural tube defects from 1988 to 1998 in Norway, Finland, Northern Netherlands, England and Wales, Ireland, France (Paris, Strasbourg, and Central East), Hungary, Italy (Emilia Romagna and Campania), Portugal, and Israel. Cases of neural tube defects were ascertained among liveborn infants, stillbirths, and pregnancy terminations (where legal). Policies and recommendations were ascertained by interview and literature review.

Main outcome measures: Incidences and trends in rates of neural tube defects before and after 1992 (the year of the first recommendations) and before and after the year of local recommendations (when applicable).

Results: The issuing of recommendations on folic acid was followed by no detectable improvement in the trends of incidence of neural tube defects.

Conclusions: Recommendations alone did not seem to influence trends in neural tube defects up to six years after the confirmation of the effectiveness of folic acid in clinical trials. New cases of neural tube defects preventable by folic acid continue to accumulate. A reasonable strategy would be to quickly integrate food fortification with fuller implementation of recommendations on supplements.

PubMed Disclaimer

Figures

Fig 1
Fig 1
Rates of neural tube defects (anencephaly and spina bifida) per 10 000 births, 1988-98. Shaded top portion indicates terminated pregnancies. Arrow indicates time of recommendations in each country. IRR=average rate of change from one year to next
Fig 2
Fig 2
Estimated number of pregnancies with neural tube defects preventable by folic acid in study area, 1993-8. Estimates assume three scenarios of effectiveness (30%, 60%, 90%), which encompass a reasonable range from low dose fortification to highly effective supplementation

References

    1. Shibuya K, Murray CJL. Congenital anomalies. In: Murray CJL, Lopez AD, eds. Health dimensions of sex and reproduction. Boston: Harvard University Press, 1998: 455-512.
    1. Centers for Disease Control and Prevention. Trends in infant mortality attributable to birth defects—United States, 1980-1995. MMWR Morb Mortal Wkly Rep 1998;47: 773-8. - PubMed
    1. Smithells RW, Sheppard S, Schorah CJ. Vitamin deficiencies and neural tube defects. Arch Dis Child 1976;51: 944-50. - PMC - PubMed
    1. Smithells RW, Sheppard S, Schorah CJ, Seller MJ, Nevin NC, Harris R, et al. Possible prevention of neural-tube defects by periconceptional vitamin supplementation. Lancet 1980;i: 339-40. - PubMed
    1. Smithells RW, Nevin NC, Seller MJ, Sheppard S, Harris R, Read AP, et al. Further experience of vitamin supplementation for prevention of neural tube defect recurrences. Lancet 1983;i: 1027-31. - PubMed

Publication types